Article Versions Notes

Falco J, Rubiu E, Broggi M, Farinotti M, Vetrano IG, Schiariti M, Anghileri E, Eoli M, Pollo B, Moscatelli M, et al. Towards an Established Intraoperative Oncological Favorable Tool: Results of Fluorescein-Guided Resection from a Monocentric, Prospective Series of 93 Primary Glioblastoma Patients. Journal of Clinical Medicine. 2023; 12(1):178. https://doi.org/10.3390/jcm12010178

Falco, Jacopo, Emanuele Rubiu, Morgan Broggi, Mariangela Farinotti, Ignazio G. Vetrano, Marco Schiariti, Elena Anghileri, Marica Eoli, Bianca Pollo, Marco Moscatelli, and et al. 2023. "Towards an Established Intraoperative Oncological Favorable Tool: Results of Fluorescein-Guided Resection from a Monocentric, Prospective Series of 93 Primary Glioblastoma Patients" Journal of Clinical Medicine 12, no. 1: 178. https://doi.org/10.3390/jcm12010178

Falco, J., Rubiu, E., Broggi, M., Farinotti, M., Vetrano, I. G., Schiariti, M., Anghileri, E., Eoli, M., Pollo, B., Moscatelli, M., Restelli, F., Mazzapicchi, E., La Corte, E., Bonomo, G., Gemma, M., Broggi, G., Ferroli, P., & Acerbi, F. (2023). Towards an Established Intraoperative Oncological Favorable Tool: Results of Fluorescein-Guided Resection from a Monocentric, Prospective Series of 93 Primary Glioblastoma Patients. Journal of Clinical Medicine, 12(1), 178. https://doi.org/10.3390/jcm12010178